Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Medicines register
Registers› Irish medicines ›Clexane 8,000 IU (80 mg) /0.8 ml Solution for Injection in pre-filled syringes
Medicines register · Ireland

Clexane 8,000 IU (80 mg) /0.8 ml Solution for Injection in pre-filled syringes

Authorisation PPA0465/477/004 · PCO Manufacturing Ltd.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
PCO Manufacturing Ltd. (all products →)
Active substance
Enoxaparin sodium
Clinical trials
22 clinical trials →
Dosage form
Solution for injection in pre-filled syringe
Route of administration
Subcutaneous use
ATC code
B01AB05
First authorised
19/11/2021
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC

Enoxaparin sodium: supply and approvals

40 authorised products on the HPRA list contain Enoxaparin sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
Enoxaparin Sodium Injection: resolved, updated 20 Oct 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 5 years (since 19 November 2021). The HPRA list does not say whether it is on sale.

Other medicines with Enoxaparin sodium in Ireland

39 other products on the HPRA list contain Enoxaparin sodium, from 6 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Clexane 10,000 IU (100mg)/1ml Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Marketed
Clexane Forte 15,000 IU (150mg)/1ml Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Marketed
Clexane 10,000 IU (100 mg)/1 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.Parallel import (PPA)Not stated
Clexane 2,000 IU (20mg)/0.2 mL Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Not stated
Clexane 4,000 IU (40 mg) /0.4 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.Parallel import (PPA)Not stated
Clexane 4,000 IU (40mg)/0.4 mL Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Not stated
Clexane 6,000 IU (60 mg) /0.6 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.Parallel import (PPA)Not stated
Clexane 6,000 IU (60mg)/0.6 mL Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Not stated
Clexane 8,000 IU (80mg)/0.8 mL Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Not stated
Clexane Forte 12,000 IU (120 mg)/0.8 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.Parallel import (PPA)Not stated
Clexane Forte 12,000 IU (120mg)/0.8 mL Solution for Injection in pre-filled syringesSanofi-Aventis Ireland Limited T/A SANOFINational authorisation (PA)Not stated
Enoxaparin sodium Ledraxen 10,000 IU (100 mg)/1 mL, solution for injection in pre-filled syringeVenipharmNational authorisation (PA)Not marketed

All 40 products with Enoxaparin sodium →

The licence holder

PCO Manufacturing Ltd. holds 288 products on the HPRA list, with 164 different active substances; 1 of the products is marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.